Mark Bryan Aguillard - Sep 20, 2023 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role: Chief Commercial Officer
Signature: /s/ Jason Miller, attorney-in-fact
Stock symbol: DMTK
Transactions as of: Sep 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/22/2023, 09:45 PM
Previous filing: Sep 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DMTK	Common Stock	Award	$0	+90K		$0.00	90K	Sep 20, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DMTK	Stock Option (right to buy)	Award	$0	+90K		$0.00	90K	Sep 20, 2023	Common Stock	90K	$1.69	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2022 Inducement Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the restricted stock units shall vest on September 20, 2024 and (ii) the remaining the remaining thirty-six forty-eighths (36/48) shall vest in twelve (12) equal installments of three forty-eighths (3/48) on the twentieth day of each third month following September 20, 2024 until the final vesting date on September 20, 2027.
F2	Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the shares of issuer common stock exercisable pursuant to this option shall vest on September 20, 2024 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in a series of thirty-six (36) equal monthly installments of one forty-eighth (1/48) over the thirty-six (36) months thereafter until the final vesting date on September 20, 2027.

Content

The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2022 Inducement Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the restricted stock units shall vest on September 20, 2024 and (ii) the remaining the remaining thirty-six forty-eighths (36/48) shall vest in twelve (12) equal installments of three forty-eighths (3/48) on the twentieth day of each third month following September 20, 2024 until the final vesting date on September 20, 2027.

Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the shares of issuer common stock exercisable pursuant to this option shall vest on September 20, 2024 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in a series of thirty-six (36) equal monthly installments of one forty-eighth (1/48) over the thirty-six (36) months thereafter until the final vesting date on September 20, 2027.